WHAT TO TRY FIRST
The Multiple Sclerosis Coalition highlights importance of starting treatment with an FDA-approved drug as soon as possible following diagnosis of relapsing remitting multiple sclerosis. Choice of initial therapy is complex and patients should work with a specialist. Options include injected therapies (such as interferon beta, glatiramer), pills (such as dimethyl fumarate) or infusions (natalizumab).
WHAT ELSE TO TRY
National institute for Health and Care Excellence. Multiple sclerosis: management of multiple sclerosis in primary and secondary care. NICE guidelines [CG186]. Published 2014.
MS Coalition. The use of disease-modifying therapies in multiple sclerosis: Principles and current evidence. Published March 2015.